chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Skin odour abnormal
Clinical narrative: sick; everything tasted like raw sewage and nothing tastes like it is supposed to; everything smelled like raw sewage and nothing smells like it is supposed to; body oil smells like raw sewage; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), AGEUSIA (everything tasted like raw sewage and nothing tastes like it is supposed to), ANOSMIA (everything smelled like raw sewage and nothing smells like it is supposed to), SKIN ODOUR ABNORMAL (body oil smells like raw sewage) and NAUSEA (nauseous) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), MORPHINE, METAXALONE (FLEXURA), PROCATEROL, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), MULTIVITAMINS [VITAMINS NOS], DILOXANIDE FUROATE, METRONIDAZOLE (DIAZOLE [DILOXANIDE FUROATE;METRONIDAZOLE]) and OMEPRAZOLE (PROPIZOLE) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick), AGEUSIA (everything tasted like raw sewage and nothing tastes like it is supposed to), ANOSMIA (everything smelled like raw sewage and nothing smells like it is supposed to), SKIN ODOUR ABNORMAL (body oil smells like raw sewage) and NAUSEA (nauseous). At the time of the report, ILLNESS (sick), AGEUSIA (everything tasted like raw sewage and nothing tastes like it is supposed to), ANOSMIA (everything smelled like raw sewage and nothing smells like it is supposed to), SKIN ODOUR ABNORMAL (body oil smells like raw sewage) and NAUSEA (nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test: unknown (Positive) Positive.         No treatment medications were provided by the reporter.   This case was linked to MOD-2021-230022 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity, Swelling
Clinical narrative: Arm was sore; It was difficult to move; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), MOBILITY DECREASED (It was difficult to move) and SWELLING (Swelling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was sore), MOBILITY DECREASED (It was difficult to move) and SWELLING (Swelling). At the time of the report, PAIN IN EXTREMITY (Arm was sore), MOBILITY DECREASED (It was difficult to move) and SWELLING (Swelling) outcome was unknown.            No concomitant medications were provided. Treatment medications were not provided. No lab data was provided by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Parosmia, SARS-CoV-2 test
Clinical narrative: Taste salty; Smell of smoke in her nose; This spontaneous case was reported by a patient and describes the occurrence of DYSGEUSIA (Taste salty) and PAROSMIA (Smell of smoke in her nose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Taste salty) and PAROSMIA (Smell of smoke in her nose). At the time of the report, DYSGEUSIA (Taste salty) and PAROSMIA (Smell of smoke in her nose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive. On 11-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medication provided by reporter. No treatment medication provided by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: delayed reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (delayed reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jun-2021, the patient experienced VACCINATION COMPLICATION (delayed reaction). At the time of the report, VACCINATION COMPLICATION (delayed reaction) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: I have some kind efdecrs/I have more sintoms about 2 dosis of moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I have some kind efdecrs/I have more sintoms about 2 dosis of moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient experienced VACCINATION COMPLICATION (I have some kind efdecrs/I have more sintoms about 2 dosis of moderna vaccine). At the time of the report, VACCINATION COMPLICATION (I have some kind efdecrs/I have more sintoms about 2 dosis of moderna vaccine) outcome was unknown. Not Provided          No concomitant medications were provided No treatment medications were provided Action taken with mRNA-1273 is not applicable   This case was linked to MOD-2021-230201 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered 2 day after the expiry date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 2 day after the expiry date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 2 day after the expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 2 day after the expiry date) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications were not reported by the reporter. No treatment mediations were reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Anxiety, Fungal infection, Nervousness
Clinical narrative: Nervousness; Anxiety; Severe yeast infection; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (Nervousness), ANXIETY (Anxiety) and FUNGAL INFECTION (Severe yeast infection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NERVOUSNESS (Nervousness), ANXIETY (Anxiety) and FUNGAL INFECTION (Severe yeast infection). At the time of the report, NERVOUSNESS (Nervousness), ANXIETY (Anxiety) and FUNGAL INFECTION (Severe yeast infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications and treatment  were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Contusion, Fatigue, Feeling abnormal
Clinical narrative: Received the second dose of vaccine after 35 days; 4th day she also had Covid arm/ a bruise of 4*3 inches; Hip pain/ joint pain; Couldn't  get out of bed during 16 days; Felt it  runaround her system/circulated all over body; Back pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt it  runaround her system/circulated all over body), BACK PAIN (Back pain), CONTUSION (4th day she also had Covid arm/ a bruise of 4*3 inches), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second dose of vaccine after 35 days) and ARTHRALGIA (Hip pain/ joint pain) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .     On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced FEELING ABNORMAL (Felt it  runaround her system/circulated all over body), BACK PAIN (Back pain), ARTHRALGIA (Hip pain/ joint pain) and FATIGUE (Couldn't  get out of bed during 16 days). On 26-Mar-2021, the patient experienced CONTUSION (4th day she also had Covid arm/ a bruise of 4*3 inches). On 19-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second dose of vaccine after 35 days). The patient was treated with ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]) at a dose of 1 dosage form. On 07-Apr-2021, FEELING ABNORMAL (Felt it  runaround her system/circulated all over body), BACK PAIN (Back pain), CONTUSION (4th day she also had Covid arm/ a bruise of 4*3 inches), ARTHRALGIA (Hip pain/ joint pain) and FATIGUE (Couldn't  get out of bed during 16 days) had resolved. On 19-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second dose of vaccine after 35 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.    This case was linked to MOD-2021-231551 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received the second dose of vaccine after 35 days; 4th day she also had Covid arm/ a bruise of 4*3 inches; Hip pain/ joint pain; Couldn't  get out of bed during 16 days; Felt it  runaround her system/circulated all over body; Back pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt it  runaround her system/circulated all over body), BACK PAIN (Back pain), CONTUSION (4th day she also had Covid arm/ a bruise of 4*3 inches), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second dose of vaccine after 35 days) and ARTHRALGIA (Hip pain/ joint pain) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .     On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced FEELING ABNORMAL (Felt it  runaround her system/circulated all over body), BACK PAIN (Back pain), ARTHRALGIA (Hip pain/ joint pain) and FATIGUE (Couldn't  get out of bed during 16 days). On 26-Mar-2021, the patient experienced CONTUSION (4th day she also had Covid arm/ a bruise of 4*3 inches). On 19-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second dose of vaccine after 35 days). The patient was treated with ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]) at a dose of 1 dosage form. On 07-Apr-2021, FEELING ABNORMAL (Felt it  runaround her system/circulated all over body), BACK PAIN (Back pain), CONTUSION (4th day she also had Covid arm/ a bruise of 4*3 inches), ARTHRALGIA (Hip pain/ joint pain) and FATIGUE (Couldn't  get out of bed during 16 days) had resolved. On 19-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second dose of vaccine after 35 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.    This case was linked to MOD-2021-231551 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: felt very sick; This spontaneous case was reported by a consumer and describes the occurrence of   in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant drugs includes : blood pressure medicine, very low dosage  Treatment medications were not provided by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Nausea, Pyrexia
Clinical narrative: Fever; Chills; Aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), MYALGIA (Aches) and NAUSEA (Nausea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included TRIAMTERENE and MECLIZINE [MECLOZINE] for an unknown indication.   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), CHILLS (Chills), MYALGIA (Aches) and NAUSEA (Nausea). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), CHILLS (Chills), MYALGIA (Aches) and NAUSEA (Nausea) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow-up was received. Reporter's email and mailing address were updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient wants to receive second dose past 35 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient wants to receive second dose past 35 days) in a 96-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient wants to receive second dose past 35 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient wants to receive second dose past 35 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: ADR form attached.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Approximately over a 100 patients were administered with doses past the 30 days expiration date.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Approximately over a 100 patients were administered with doses past the 30 days expiration date.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Approximately over a 100 patients were administered with doses past the 30 days expiration date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Approximately over a 100 patients were administered with doses past the 30 days expiration date.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Inflammation, Pain in extremity, Sciatica
Clinical narrative: pain in his lower back; Pain radiates down legs; sounds like Sciatica; pain in hips; inflammation in his lower back and hips; This spontaneous case was reported by a pharmacist and describes the occurrence of BACK PAIN (pain in his lower back), PAIN IN EXTREMITY (Pain radiates down legs), SCIATICA (sounds like Sciatica), ARTHRALGIA (pain in hips) and INFLAMMATION (inflammation in his lower back and hips) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BACK PAIN (pain in his lower back), PAIN IN EXTREMITY (Pain radiates down legs), SCIATICA (sounds like Sciatica), ARTHRALGIA (pain in hips) and INFLAMMATION (inflammation in his lower back and hips). At the time of the report, BACK PAIN (pain in his lower back), PAIN IN EXTREMITY (Pain radiates down legs), SCIATICA (sounds like Sciatica), ARTHRALGIA (pain in hips) and INFLAMMATION (inflammation in his lower back and hips) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  The patient was prescribed with Steroid injections.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 1st dose 2 Feb2021 patient did not get 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st dose 2 Feb2021 patient did not get 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose 2 Feb2021 patient did not get 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (1st dose 2 Feb2021 patient did not get 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was provided by the reporter.  No treatment medication was provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered 2 day after the expiry date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 2 day after the expiry date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 2 day after the expiry date). On 19-Jun-2021, EXPIRED PRODUCT ADMINISTERED (administered 2 day after the expiry date) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Description of Event or Problem: A total of 10 patients received the vaccine on 19Jun2021 from Lot number 036C21A at the pharmacy. Pharmacist does not know if any patients has symptoms but is planning to do a flow up call with the patients. No concomitants were reported. No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia, Peripheral swelling
Clinical narrative: Swelling in the arm; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in the arm), HEADACHE (headache) and MYALGIA (Body aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical History information was reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling in the arm), HEADACHE (headache) and MYALGIA (Body aches). At the time of the report, PERIPHERAL SWELLING (swelling in the arm), HEADACHE (headache) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not provided by the reporter. Treatment medication were not provided by the reporter.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Myalgia, Nausea
Clinical narrative: feels like having the flu; Chills; light headache; sore arm; nausea; feels like vomiting; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like having the flu), CHILLS (Chills), HEADACHE (light headache), MYALGIA (sore arm) and NAUSEA (nausea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (feels like having the flu), CHILLS (Chills), HEADACHE (light headache), MYALGIA (sore arm), NAUSEA (nausea) and VOMITING (feels like vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, INFLUENZA LIKE ILLNESS (feels like having the flu), CHILLS (Chills), HEADACHE (light headache), MYALGIA (sore arm), NAUSEA (nausea) and VOMITING (feels like vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: feels like having the flu; Chills; light headache; sore arm; nausea; feels like vomiting; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like having the flu), CHILLS (Chills), HEADACHE (light headache), MYALGIA (sore arm) and NAUSEA (nausea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (feels like having the flu), CHILLS (Chills), HEADACHE (light headache), MYALGIA (sore arm), NAUSEA (nausea) and VOMITING (feels like vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, INFLUENZA LIKE ILLNESS (feels like having the flu), CHILLS (Chills), HEADACHE (light headache), MYALGIA (sore arm), NAUSEA (nausea) and VOMITING (feels like vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received second dose on day 47 from first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second dose on day 47 from first dose) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 009C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second dose on day 47 from first dose). On 21-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second dose on day 47 from first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medicines was not reported by reporter . Treatment information was not provided . The action taken with mRNA-1273 with the events was considered as not applicable
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: had swelling under her right arm down to her breast and on the back of her arm.; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (had swelling under her right arm down to her breast and on the back of her arm.) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced SWELLING (had swelling under her right arm down to her breast and on the back of her arm.). At the time of the report, SWELLING (had swelling under her right arm down to her breast and on the back of her arm.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itching all over the body (Both Arms and Legs); Rash became visible on both arms but mainly on Injected Arm; Itching Right Arm Injection Site; Bad Rash Right Arm Injection Site (Baseball Size); This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over the body (Both Arms and Legs)), RASH (Rash became visible on both arms but mainly on Injected Arm), VACCINATION SITE PRURITUS (Itching Right Arm Injection Site) and VACCINATION SITE RASH (Bad Rash Right Arm Injection Site (Baseball Size)) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jun-2021, the patient experienced RASH (Rash became visible on both arms but mainly on Injected Arm), VACCINATION SITE PRURITUS (Itching Right Arm Injection Site) and VACCINATION SITE RASH (Bad Rash Right Arm Injection Site (Baseball Size)). On 20-Jun-2021, the patient experienced PRURITUS (Itching all over the body (Both Arms and Legs)). At the time of the report, PRURITUS (Itching all over the body (Both Arms and Legs)), RASH (Rash became visible on both arms but mainly on Injected Arm), VACCINATION SITE PRURITUS (Itching Right Arm Injection Site) and VACCINATION SITE RASH (Bad Rash Right Arm Injection Site (Baseball Size)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15-7-2021 contains no new information
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: swelling came back; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling came back) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053cz1a and 027c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SWELLING (swelling came back). At the time of the report, SWELLING (swelling came back) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable. No concomitants were reported. No treatment medication were reported.   This case was linked to MOD-2021-230063 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: throwing up after Moderna Covid19 Vaccine first dose; This spontaneous case was reported by a patient and describes the occurrence of VOMITING (throwing up after Moderna Covid19 Vaccine first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (throwing up after Moderna Covid19 Vaccine first dose). At the time of the report, VOMITING (throwing up after Moderna Covid19 Vaccine first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported.  No Treatment were reported.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Malaise, Night sweats, Pyrexia
Clinical narrative: Not feeling well; Fever; Fatigue; Night sweats; Does not feel good; Losing weight; This spontaneous case was reported by a physician and describes the occurrence of NIGHT SWEATS (Night sweats), FEELING ABNORMAL (Does not feel good), WEIGHT DECREASED (Losing weight), MALAISE (Not feeling well) and PYREXIA (Fever) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced NIGHT SWEATS (Night sweats), FEELING ABNORMAL (Does not feel good), WEIGHT DECREASED (Losing weight), PYREXIA (Fever) and FATIGUE (Fatigue). On an unknown date, the patient experienced MALAISE (Not feeling well). At the time of the report, NIGHT SWEATS (Night sweats), FEELING ABNORMAL (Does not feel good), WEIGHT DECREASED (Losing weight), MALAISE (Not feeling well), PYREXIA (Fever) and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications details provided. No treatment details provided.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: Not feeling well; Fever; Fatigue; Night sweats; Does not feel good; Losing weight; This spontaneous case was reported by a physician and describes the occurrence of NIGHT SWEATS (Night sweats), FEELING ABNORMAL (Does not feel good), WEIGHT DECREASED (Losing weight), MALAISE (Not feeling well) and PYREXIA (Fever) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced NIGHT SWEATS (Night sweats), FEELING ABNORMAL (Does not feel good), WEIGHT DECREASED (Losing weight), PYREXIA (Fever) and FATIGUE (Fatigue). On an unknown date, the patient experienced MALAISE (Not feeling well). At the time of the report, NIGHT SWEATS (Night sweats), FEELING ABNORMAL (Does not feel good), WEIGHT DECREASED (Losing weight), MALAISE (Not feeling well), PYREXIA (Fever) and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications details provided. No treatment details provided.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Myalgia, Peripheral swelling
Clinical narrative: Swollen arm after my second shot; Red arm; Hurts arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm after my second shot), ERYTHEMA (Red arm) and MYALGIA (Hurts arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm after my second shot), ERYTHEMA (Red arm) and MYALGIA (Hurts arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm after my second shot), ERYTHEMA (Red arm) and MYALGIA (Hurts arm) outcome was unknown. Not Provided          No concomitant medication was reported. Treatment medication was not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Vaginal Spotting (Bleeding) after Second dose; This spontaneous case was reported by an other caregiver and describes the occurrence of VAGINAL HAEMORRHAGE (Vaginal Spotting (Bleeding) after Second dose) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced VAGINAL HAEMORRHAGE (Vaginal Spotting (Bleeding) after Second dose). At the time of the report, VAGINAL HAEMORRHAGE (Vaginal Spotting (Bleeding) after Second dose) outcome was unknown. Not Provided          No concomitant medications were provided No treatment medications were provided   Reporter did not allow further contact
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site urticaria
Clinical narrative: Vaccination site swelling; Welts Injection Site; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE URTICARIA (Welts Injection Site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE URTICARIA (Welts Injection Site). At the time of the report, VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE URTICARIA (Welts Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitent medications were provided.  No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: The patch they put on my arm itches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (The patch they put on my arm itches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (The patch they put on my arm itches). At the time of the report, VACCINATION SITE PRURITUS (The patch they put on my arm itches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided concomitant medications were not provided
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Muscle spasms, Muscle twitching
Clinical narrative: muscle spasm by the injection site; its like twitching sensation under the muscle / Twitching is all over her body; Feels like she has a bug on her legs, but she doesn't; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE SPASMS (muscle spasm by the injection site), MUSCLE TWITCHING (its like twitching sensation under the muscle / Twitching is all over her body) and FEELING ABNORMAL (Feels like she has a bug on her legs, but she doesn't) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H20A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (muscle spasm by the injection site), MUSCLE TWITCHING (its like twitching sensation under the muscle / Twitching is all over her body) and FEELING ABNORMAL (Feels like she has a bug on her legs, but she doesn't). At the time of the report, MUSCLE SPASMS (muscle spasm by the injection site), MUSCLE TWITCHING (its like twitching sensation under the muscle / Twitching is all over her body) and FEELING ABNORMAL (Feels like she has a bug on her legs, but she doesn't) outcome was unknown. Not Provided          Concomitant medications were not provided by reporter. Treatment medications were not provided.   This case was linked to MOD-2021-231175 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (cough). At the time of the report, COUGH (cough) outcome was unknown.            Concomitant medications were not reported. Treatment information was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: had one of moderna at (PII removed) market now they dont give out vaccine anymore. I need one more vaccines; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jun-2021 and was forwarded to the company on 21-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (had one of moderna at (PII removed) market now they dont give out vaccine anymore. I need one more vaccines) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (had one of moderna at (PII removed) market now they dont give out vaccine anymore. I need one more vaccines). At the time of the report, PRODUCT DOSE OMISSION ISSUE (had one of moderna at (PII removed) market now they dont give out vaccine anymore. I need one more vaccines) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were provided. No treatment medication were provided
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Chest pain, Myalgia
Clinical narrative: Anxiety; Every now and then throughout the day, I have pain about my heart pocket; Muscle ache; This spontaneous case was reported by a pharmacist and describes the occurrence of MYALGIA (muscle ache), ANXIETY (Anxiety) and CHEST PAIN (Every now and then throughout the day, I have pain about my heart pocket   ) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CELECOXIB (CELEBREX), AMLODIPINE, HYDROCHLOROTHIAZIDE and IRBESARTAN for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle ache), ANXIETY (Anxiety) and CHEST PAIN (Every now and then throughout the day, I have pain about my heart pocket   ). The patient was treated with MELOXICAM for Muscle ache, at an unspecified dose and frequency. At the time of the report, MYALGIA (muscle ache), ANXIETY (Anxiety) and CHEST PAIN (Every now and then throughout the day, I have pain about my heart pocket   ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Headache, T-lymphocyte count abnormal
Clinical narrative: Head ache; his t cells are messed up; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jun-2021 and was forwarded to Moderna on 22-Jun-2021.    This spontaneous case was reported by a patient family member or friend and describes the occurrence of T-LYMPHOCYTE COUNT ABNORMAL (his t cells are messed up) and HEADACHE (Head ache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced T-LYMPHOCYTE COUNT ABNORMAL (his t cells are messed up) and HEADACHE (Head ache). At the time of the report, T-LYMPHOCYTE COUNT ABNORMAL (his t cells are messed up) and HEADACHE (Head ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported No treatment medication were reported.